Paper published in a journal (Scientific congresses and symposiums)
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE/TRIO-012 trial
Damaraju, Sambasivarao; Gorbunova, Vera; Gelmon, Karen A. et al.
2015In Journal of Clinical Oncology, (suppl abstr 540)
Peer Reviewed verified by ORBi
 

Files


Full Text
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE-TRIO012 trial - abstract.pdf
Publisher postprint (762.74 kB)
Request a copy
Annexes
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE_TRI.pdf
Publisher postprint (850.24 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
oncology; breast cancer
Disciplines :
Oncology
Author, co-author :
Damaraju, Sambasivarao
Gorbunova, Vera
Gelmon, Karen A.
Garcia Saenz, Jose Angel
Morales, Serafin
Abigerges, Dany Youssef
Canon, Jean-Luc
Lifirenko, Igor
Cohen, Graham Lawrence
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Thireau, François
Fresco, Rodrigo
Houé, Vincent
Press, Michael F.
Narasimhan, Ashok
Mackey, John Robert
More authors (6 more) Less
Language :
English
Title :
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE/TRIO-012 trial
Publication date :
2015
Event name :
2015 ASCO Annual Meeting
Event date :
May 29-June2 2015
Audience :
International
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
American Society of Clinical Oncology, Alexandria, United States - Virginia
Issue :
suppl abstr 540
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 14 January 2016

Statistics


Number of views
53 (1 by ULiège)
Number of downloads
2 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi